Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Lung Neoplasms 2Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Lip Neoplasms 1Esthesioneuroblastoma, Olfactory 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

pembrolizumab 1ficlatuzumab 1durvalumab 1Radiotherapy, Intensity-Modulated 1Phlebotomy 1Metabolic Flux Analysis 1Cisplatin 1Cetuximab 1Carboplatin 1Blood Specimen Collection 1Allovectin-7 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lip Neoplasms × Phlebotomy × Head & Neck × Clear all
NCT00568490 2025-07-02

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Stanford University

Recruiting
200 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lip Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡